Ritz, I have moved a lot of other investment money
Post# of 155475
(Total Views: 619)
Posted On: 05/17/2020 6:25:15 PM
Re: Riztheinvestor #34262
Ritz, I have moved a lot of other investment money into CYDY too. The stats are simply staggering across so many indications. Like the potential for treating severe flu to name just one.
It is simple, as in not some wildly complex gene edit costing hundreds of thousands of dollars per dose. My wife was cured with a simple autologous stem cell transplant (wildly expensive but simple in nature) and survived the major cause of failure/death which is infections after wiping out the immune system (brutal). True and pure simple is good, leronlimab is simple and could be the Achilles heel of a long list. I am big fan of simple, it is out there and it will be found. I suspect we have found one here.
As for other simple drugs? I am keeping only one in my portfolio. SM-88, it attacks the cancer cell’s protein synthesis (starves it to death with a proprietary dysfunctional tyrosine derivative) with 3 other off the shelf approved drugs in combo. It has shown to be effective in 15 cancer types. https://www.tymeinc.com/pipeline/sm-88-overview/default.aspx
It is simple, as in not some wildly complex gene edit costing hundreds of thousands of dollars per dose. My wife was cured with a simple autologous stem cell transplant (wildly expensive but simple in nature) and survived the major cause of failure/death which is infections after wiping out the immune system (brutal). True and pure simple is good, leronlimab is simple and could be the Achilles heel of a long list. I am big fan of simple, it is out there and it will be found. I suspect we have found one here.
As for other simple drugs? I am keeping only one in my portfolio. SM-88, it attacks the cancer cell’s protein synthesis (starves it to death with a proprietary dysfunctional tyrosine derivative) with 3 other off the shelf approved drugs in combo. It has shown to be effective in 15 cancer types. https://www.tymeinc.com/pipeline/sm-88-overview/default.aspx
(0)
(0)